Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer

被引：16

作者：

Fouchard, Maxime ^{[1
]}

Jantzem, Helene ^{[2
]}

Quere, Gilles ^{[1
]}

Descourt, Renaud ^{[1
]}

Robinet, Gilles ^{[1
]}

Poureau, Pierre-Guillaume ^{[1
]}

机构：

[1] Univ Hosp, Dept Oncol, F-29609 Brest, France

[2] Univ Hosp, Dept Pharmacovigilance, Brest, France

来源：

EUROPEAN JOURNAL OF CANCER | 2019年 / 115卷

关键词：

Immunotherapy; Cholangitis; Immune adverse event; NIVOLUMAB;

D O I：

10.1016/j.ejca.2019.04.022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：107 / 110

页数：4

共 5 条

[1] EASL Clinical Practice Guidelines: Management of cholestatic liver diseases [J].

Beuers, Ulrich ;

Boberg, Kirsten M. ;

Chapman, Roger W. ;

Chazouilleres, Olivier ;

Invernizzi, Pietro ;

Jones, David E. J. ;

Lammert, Frank ;

Pares, Albert ;

Trauner, Michael .

JOURNAL OF HEPATOLOGY, 2009, 51 (02) :237-267

[2] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline [J].

Brahmer, Julie R. ;

Lacchetti, Christina ;

Schneider, Bryan J. ;

Atkins, Michael B. ;

Brassil, Kelly J. ;

Caterino, Jeffrey M. ;

Chau, Ian ;

Ernstoff, Marc S. ;

Gardner, Jennifer M. ;

Ginex, Pamela ;

Hallmeyer, Sigrun ;

Chakrabarty, Jennifer Holter ;

Leighl, Natasha B. ;

Mammen, Jennifer S. ;

McDermott, David F. ;

Naing, Aung ;

Nastoupil, Loretta J. ;

Phillips, Tanyanika ;

Porter, Laura D. ;

Puzanov, Igor ;

Reichner, Cristina A. ;

Santomasso, Bianca D. ;

Seigel, Carole ;

Spira, Alexander ;

Suarez-Almazor, Maria E. ;

Wang, Yinghong ;

Weber, Jeffrey S. ;

Wolchok, Jedd D. ;

Thompson, John A. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) :1714-+

[3] Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury [J].

Gelsomino, F. ;

Vitale, G. ;

D'Errico, A. ;

Bertuzzi, C. ;

Andreone, P. ;

Ardizzoni, A. .

ANNALS OF ONCOLOGY, 2017, 28 (03) :671-672

[4] A case of nivolumab-related cholangitis and literature review: how to look for the right tools for a correct diagnosis of this rare immune-related adverse event [J].

Gelsomino, Francesco ;

Vitale, Giovanni ;

Ardizzoni, Andrea .

INVESTIGATIONAL NEW DRUGS, 2018, 36 (01) :144-146

[5] Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report [J].

Kashima, Jumpei ;

Okuma, Yusuke ;

Shimizuguchi, Ryoko ;

Chiba, Kazuro .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (01) :61-65

← 1 →